Clinical Trials Directory

Trials / Conditions / Adult Synovial Sarcoma

Adult Synovial Sarcoma

11 registered clinical trials studyying Adult Synovial Sarcoma.

StatusTrialSponsorPhase
WithdrawnNY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid
NCT02059850
Fred Hutchinson Cancer CenterPhase 1
CompletedGemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
NCT01532687
OHSU Knight Cancer InstitutePhase 2
CompletedAutologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Ca
NCT01477021
Fred Hutchinson Cancer CenterPhase 1
CompletedEverolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent
NCT01281865
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced
NCT01154452
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedCixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
NCT00831844
National Cancer Institute (NCI)Phase 2
CompletedCixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta
NCT00720174
National Cancer Institute (NCI)Phase 1
CompletedObservation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft
NCT00346164
Children's Oncology GroupPhase 3
CompletedIxabepilone in Treating Young Patients With Refractory Solid Tumors
NCT00331643
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
NCT00245102
National Cancer Institute (NCI)Phase 2
CompletedDepsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
NCT00112463
National Cancer Institute (NCI)Phase 2